Literature DB >> 15362182

Deriving welfare measures in discrete choice experiments: a comment to Lancsar and Savage (1).

Mandy Ryan1.   

Abstract

Lancsar and Savage argue that current methods of deriving welfare estimates, using discrete choice experiments, are inconsistent with random utility and welfare theory. In this paper I show that this not the case. The general formula proposed by Small and Rosen for estimating welfare, which Lancsar and Savage claim should be used, reduces to the method used by health economists for state of the world models. The important question then becomes when are state of the world models, as opposed to multiple alternative models, appropriate?

Mesh:

Year:  2004        PMID: 15362182     DOI: 10.1002/hec.869

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  11 in total

1.  Using discrete choice experiments within a cost-benefit analysis framework: some considerations.

Authors:  Emma McIntosh
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

2.  Preferences of community pharmacists for extended roles in primary care: a survey and discrete choice experiment.

Authors:  Anthony Scott; Christine Bond; Jackie Inch; Aileen Grant
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

3.  Public preferences for establishing nephrology facilities in Greenland: estimating willingness-to-pay using a discrete choice experiment.

Authors:  Trine Kjær; Mickael Bech; Christian Kronborg; Morten Raun Mørkbak
Journal:  Eur J Health Econ       Date:  2012-09-14

4.  How does cost matter in health-care discrete-choice experiments?

Authors:  F Reed Johnson; Ateesha F Mohamed; Semra Ozdemir; Deborah A Marshall; Kathryn A Phillips
Journal:  Health Econ       Date:  2011-03       Impact factor: 3.046

5.  Physician office vs retail clinic: patient preferences in care seeking for minor illnesses.

Authors:  Arif Ahmed; Jack E Fincham
Journal:  Ann Fam Med       Date:  2010 Mar-Apr       Impact factor: 5.166

6.  Recombinant erythropoietin for chemotherapy-related anaemia: economic value and health-related quality-of-life assessment using direct utility elicitation and discrete choice experiment methods.

Authors:  Diego F Ossa; Andrew Briggs; Emma McIntosh; Warren Cowell; Tim Littlewood; Mark Sculpher
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

7.  The prioritization preferences of pan-Canadian Oncology Drug Review members and the Canadian public: a stated-preferences comparison.

Authors:  C Skedgel
Journal:  Curr Oncol       Date:  2016-10-25       Impact factor: 3.677

8.  How do physician assessments of patient preferences for colorectal cancer screening tests differ from actual preferences? A comparison in Canada and the United States using a stated-choice survey.

Authors:  Deborah A Marshall; F Reed Johnson; Nathalie A Kulin; Semra Ozdemir; Judith M E Walsh; John K Marshall; Stephanie Van Bebber; Kathryn A Phillips
Journal:  Health Econ       Date:  2009-12       Impact factor: 3.046

9.  What, who and when? Incorporating a discrete choice experiment into an economic evaluation.

Authors:  Michela Tinelli; Mandy Ryan; Christine Bond
Journal:  Health Econ Rev       Date:  2016-07-29

10.  Discrete-choice modelling of patient preferences for modes of drug administration.

Authors:  Ebenezer Kwabena Tetteh; Steve Morris; Nigel Titcheneker-Hooker
Journal:  Health Econ Rev       Date:  2017-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.